Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 2
1984 3
1985 6
1986 5
1987 6
1988 2
1989 6
1990 6
1991 13
1992 15
1993 10
1994 9
1995 15
1996 15
1997 30
1998 31
1999 38
2000 41
2001 40
2002 31
2003 22
2004 24
2005 27
2006 31
2007 30
2008 30
2009 23
2010 24
2011 22
2012 18
2013 14
2014 17
2015 15
2016 13
2017 16
2018 8
2019 13
2020 11
2021 11
2022 7
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

671 results

Results by year

Filters applied: . Clear all
Page 1
Danaparoid sodium.
Acostamadiedo JM, Iyer UG, Owen J. Acostamadiedo JM, et al. Expert Opin Pharmacother. 2000 May;1(4):803-14. doi: 10.1517/14656566.1.4.803. Expert Opin Pharmacother. 2000. PMID: 11249517 Review.
Danaparoid sodium (Orgaran, Organon) is a heparinoid glycosamino-glycuronan antithrombotic agent approved for the prophylaxis of post-operative deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE) in patients undergoing elective hip replacement surg …
Danaparoid sodium (Orgaran, Organon) is a heparinoid glycosamino-glycuronan antithrombotic agent approved for the prophylaxis …
[Danaparoid sodium].
Kitazawa Y. Kitazawa Y. Rinsho Byori. 2011 Feb;Suppl 147:164-6. Rinsho Byori. 2011. PMID: 21761765 Review. Japanese. No abstract available.
Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
Hayashi T, Takatori H, Horii R, Nio K, Terashima T, Iida N, Kitahara M, Shimakami T, Arai K, Kitamura K, Kawaguchi K, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Toyama T, Okumura K, Kozaka K, Kaneko S. Hayashi T, et al. BMC Gastroenterol. 2019 Dec 16;19(1):217. doi: 10.1186/s12876-019-1140-8. BMC Gastroenterol. 2019. PMID: 31842768 Free PMC article.
In this study, we examined the effectiveness and safety of anticoagulation therapy using danaparoid sodium for PVT in patients with cirrhosis. METHODS: This retrospective study assessed 52 cirrhotic patients with PVT treated with danaparoid sodium for …
In this study, we examined the effectiveness and safety of anticoagulation therapy using danaparoid sodium for PVT in patients …
Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Garcia DA, Baglin TP, Weitz JI, Samama MM. Garcia DA, et al. Chest. 2012 Feb;141(2 Suppl):e24S-e43S. doi: 10.1378/chest.11-2291. Chest. 2012. PMID: 22315264 Free PMC article. Review.
These include the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight heparins (LMWHs), fondaparinux, and danaparoid, as well as the direct thrombin inhibitors hirudin, bivalirudin, and argatroban. ...Three additional parenteral direct thrombin inhi …
These include the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight heparins (LMWHs), fondaparinux, and danapar …
Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients.
Severin T, Zieger B, Sutor AH. Severin T, et al. Semin Thromb Hemost. 2002 Oct;28(5):447-54. doi: 10.1055/s-2002-35285. Semin Thromb Hemost. 2002. PMID: 12420240 Review.
Alternative anticoagulation applied in pediatric patients mainly included danaparoid sodium and recombinant hirudin. In most patients treated with these anticoagulants, effective anticoagulation and clinical improvement were observed. ...
Alternative anticoagulation applied in pediatric patients mainly included danaparoid sodium and recombinant hirudin. In most p …
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N. Cuker A, et al. Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489. Blood Adv. 2018. PMID: 30482768 Free PMC article.
Conditional recommendations include the choice among non-heparin anticoagulants (argatroban, bivalirudin, danaparoid, fondaparinux, direct oral anticoagulants) for treatment of acute HIT....
Conditional recommendations include the choice among non-heparin anticoagulants (argatroban, bivalirudin, danaparoid, fondaparinux, d …
Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective Analysis.
Minakata D, Fujiwara SI, Hayakawa J, Nakasone H, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Umino K, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Sugimoto M, Ishihara Y, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Ohmori T, Kanda Y. Minakata D, et al. Acta Haematol. 2020;143(3):250-259. doi: 10.1159/000501818. Epub 2019 Aug 28. Acta Haematol. 2020. PMID: 31461700
BACKGROUND: Danaparoid sodium and synthetic protease inhibitors (SPIs) have been approved for the treatment of disseminated intravascular coagulation (DIC) in Japan. ...RESULTS: DIC resolution rate in the danaparoid group was higher than that in the SPIs grou …
BACKGROUND: Danaparoid sodium and synthetic protease inhibitors (SPIs) have been approved for the treatment of disseminated in …
Danaparoid sodium attenuates the effects of heat stress.
Hagiwara S, Iwasaka H, Shingu C, Matsumoto S, Uchida T, Nishida T, Mizunaga S, Saikawa T, Noguchi T. Hagiwara S, et al. J Surg Res. 2011 Dec;171(2):762-8. doi: 10.1016/j.jss.2010.05.008. Epub 2010 Jun 1. J Surg Res. 2011. PMID: 20673918
BACKGROUND: Heat stroke is a condition characterized by high body temperature that can lead to hemorrhage and necrosis in multiple organs. Anticoagulants, such as danaparoid sodium (DA), inhibit various types of inflammation; however, the anti-inflammatory mechanism …
BACKGROUND: Heat stroke is a condition characterized by high body temperature that can lead to hemorrhage and necrosis in multiple organs. A …
Danaparoid sodium prevents cerulein-induced acute pancreatitis in rats.
Hagiwara S, Iwasaka H, Uchida T, Hasegawa A, Asai N, Noguchi T. Hagiwara S, et al. Shock. 2009 Jul;32(1):94-9. doi: 10.1097/SHK.0b013e31818ec2c2. Shock. 2009. PMID: 18948846
Systemic inflammatory mediators, including the protein high-mobility group box 1 (HMGB1), play an important role in the development of acute pancreatitis. Anticoagulants such as danaparoid sodium (DA) may be able to inhibit sepsis-induced inflammation, but the mecha …
Systemic inflammatory mediators, including the protein high-mobility group box 1 (HMGB1), play an important role in the development of acute …
671 results